For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of DENTSPLY Sirona Inc (NASDAQ: XRAY) was $26.06 for the day, down -1.25% from the previous closing price of $26.39. In other words, the price has decreased by -$1.25 from its previous closing price. On the day, 1.69 million shares were traded. XRAY stock price reached its highest trading level at $26.385 during the session, while it also had its lowest trading level at $25.99.
Ratios:
Our analysis of XRAY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.39. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.57.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $42.
On November 16, 2023, Needham started tracking the stock assigning a Buy rating and target price of $35.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 31 ’24 when LUCIER GREGORY T bought 3,577 shares for $27.95 per share. The transaction valued at 99,976 led to the insider holds 58,374 shares of the business.
LUCIER GREGORY T bought 10,000 shares of XRAY for $314,400 on Nov 22 ’23. The Director now owns 43,121 shares after completing the transaction at $31.44 per share. On Nov 20 ’23, another insider, Coleman Glenn, who serves as the Executive VP & CFO of the company, bought 10,000 shares for $29.70 each. As a result, the insider paid 297,000 and bolstered with 73,566 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 5479375360 and an Enterprise Value of 7352852480. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.37 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 1.866 whereas that against EBITDA is 11.727.
Stock Price History:
The Beta on a monthly basis for XRAY is 1.02, which has changed by -0.35606623 over the last 52 weeks, in comparison to a change of 0.21656322 over the same period for the S&P500. Over the past 52 weeks, XRAY has reached a high of $41.65, while it has fallen to a 52-week low of $23.94. The 50-Day Moving Average of the stock is -2.03%, while the 200-Day Moving Average is calculated to be -16.01%.
Shares Statistics:
XRAY traded an average of 2.82M shares per day over the past three months and 2739160 shares per day over the past ten days. A total of 207.20M shares are outstanding, with a floating share count of 206.07M. Insiders hold about 0.75% of the company’s shares, while institutions hold 102.69% stake in the company. Shares short for XRAY as of 1719532800 were 13303014 with a Short Ratio of 4.73, compared to 1717113600 on 12880869. Therefore, it implies a Short% of Shares Outstanding of 13303014 and a Short% of Float of 7.32.
Dividends & Splits
With its trailing 12-month dividend rate of 0.58, XRAY has a forward annual dividend rate of 0.60. Against a Trailing Annual Dividend Yield of 0.021978023The stock’s 5-year Average Dividend Yield is 1.11.
